Search research articles
Contact Us
Filters
Showing results (461-470 of 602) with videos related to
Page
of 61
Sort By:
American Journal of Hematology
|
October 4, 2025
Clinical Characteristics, Treatment Responses and Outcomes of Light Chain Multiple Myeloma
Abiola Bolarinwa, Saurabh Zanwar, Nadine Abdallah, et al.
Blood Advances
|
January 30, 2025
Solitary plasmacytoma: single-institution experience, and systematic review and meta-analysis of clinical outcomes
Charalampos Charalampous, Jean-Sebastien Claveau, Prashant Kapoor, et al.
Blood Cancer Journal
|
December 13, 2018
Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome
Ashley R Paquin, Shaji K Kumar, Francis K Buadi, et al.
American Journal of Hematology
|
September 9, 2018
Utility and prognostic value of <sup>18</sup> F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma
Mohammed A Aljama, M Hasib Sidiqi, Francis K Buadi, et al.
Blood
|
March 28, 2009
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone
Prashant Kapoor, Shaji Kumar, Rafael Fonseca, et al.
Leukemia
|
July 31, 2020
Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis
Eli Muchtar, Morie A Gertz, Taxiarchis V Kourelis, et al.
European Journal of Haematology
|
March 8, 2020
c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma
Alessandra Di Bacco, Nizar J Bahlis, Nikhil C Munshi, et al.
American Journal of Hematology
|
December 29, 2018
Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method
Surbhi Sidana, Dragan Jevremovic, Rhett P Ketterling, et al.
Blood
|
October 22, 2017
Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients
Hervé Avet-Loiseau, Nizar J Bahlis, Wee-Joo Chng, et al.
Blood
|
January 28, 2017
Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death
Eli Muchtar, Morie A Gertz, Shaji K Kumar, et al.
Page
of 61
Search research articles
Search
Showing results (461-470 of 602) with videos related to
Sort By:
Page
of 61
American Journal of Hematology
|
October 4, 2025
Clinical Characteristics, Treatment Responses and Outcomes of Light Chain Multiple Myeloma
Abiola Bolarinwa, Saurabh Zanwar, Nadine Abdallah, et al.
Blood Advances
|
January 30, 2025
Solitary plasmacytoma: single-institution experience, and systematic review and meta-analysis of clinical outcomes
Charalampos Charalampous, Jean-Sebastien Claveau, Prashant Kapoor, et al.
Blood Cancer Journal
|
December 13, 2018
Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome
Ashley R Paquin, Shaji K Kumar, Francis K Buadi, et al.
American Journal of Hematology
|
September 9, 2018
Utility and prognostic value of <sup>18</sup> F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma
Mohammed A Aljama, M Hasib Sidiqi, Francis K Buadi, et al.
Blood
|
March 28, 2009
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone
Prashant Kapoor, Shaji Kumar, Rafael Fonseca, et al.
Leukemia
|
July 31, 2020
Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis
Eli Muchtar, Morie A Gertz, Taxiarchis V Kourelis, et al.
European Journal of Haematology
|
March 8, 2020
c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma
Alessandra Di Bacco, Nizar J Bahlis, Nikhil C Munshi, et al.
American Journal of Hematology
|
December 29, 2018
Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method
Surbhi Sidana, Dragan Jevremovic, Rhett P Ketterling, et al.
Blood
|
October 22, 2017
Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients
Hervé Avet-Loiseau, Nizar J Bahlis, Wee-Joo Chng, et al.
Blood
|
January 28, 2017
Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death
Eli Muchtar, Morie A Gertz, Shaji K Kumar, et al.
Page
of 61